Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optic chiasmatic-hypothalamic glioma

E Alshail1, J T Rutka, L E Becker

  • 1Division of Neurosurgery, Hospital for Sick Children, University of Toronto, ON, Canada.

Brain Pathology (Zurich, Switzerland)
|April 1, 1997
PubMed
Summary

Optic chiasmatic-hypothalamic gliomas (OCHGs) can exhibit aggressive growth, particularly in young children and adults. Treatment strategies for OCHGs vary based on tumor presentation and patient age, often involving conservative management or surgical intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Use of monopolar cautery in patient with a vagal nerve stimulator during neuromuscular scoliosis surgery.

Spine deformity·2023
Same author

Use of monopolar cautery in patient with a vagal nerve stimulator during neuromuscular scoliosis surgery.

Spine deformity·2023
Same author

Newborn Hearing Screenings in Human Immunodeficiency Virus-Exposed Uninfected Infants.

Journal of AIDS and immune research·2017
Same author

Fall frequency and associated factors among men and women with or at risk for HIV infection.

HIV medicine·2016
Same author

Epilepsy surgery: recent advances in brain mapping, neuroimaging and surgical procedures.

Journal of neurosurgical sciences·2015
Same author

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.

Nature·2014

Area of Science:

  • Neuro-oncology
  • Pediatric Neurosurgery

Background:

  • Optic chiasmatic-hypothalamic gliomas (OCHGs) are often histologically benign but can present with significant morbidity and mortality.
  • Tumor behavior is age-dependent, with aggressive growth noted in patients under five and over 20 years old.
  • Lack of specific pathological markers complicates prediction of clinical behavior.

Purpose of the Study:

  • To review the clinical behavior and treatment outcomes of optic chiasmatic-hypothalamic gliomas.
  • To establish treatment recommendations based on available clinical data and imaging advancements.

Main Methods:

  • Review of clinical series and natural history data for OCHGs.
  • Utilization of modern imaging techniques like MRI for disease monitoring.
  • Analysis of treatment responses to conservative management, surgery, chemotherapy, and radiation therapy.

Related Experiment Videos

Main Results:

  • Most OCHG patients survive long-term, but aggressive growth occurs in specific age groups.
  • Magnetic resonance imaging (MRI) aids in monitoring disease progression and treatment efficacy.
  • Conservative management (CSF shunting, medical therapy) is recommended for OCHGs without visual failure, especially in NF-1 patients.

Conclusions:

  • Treatment for OCHGs should be tailored to individual patient factors, including age, visual status, and neurological deficits.
  • Surgical intervention is indicated for progressive neurological deficits or visual deterioration.
  • Chemotherapy and radiation therapy are considered for refractory or progressive disease, with radiation reserved for children over five.